Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,287 | 814 | 98.8% |
| Education | $150.18 | 8 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,138 | 180 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,197 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,168 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,021 | 63 | $0 (2024) |
| Amarin Pharma Inc. | $878.52 | 45 | $0 (2022) |
| Novo Nordisk Inc | $818.55 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $765.50 | 44 | $0 (2021) |
| Astellas Pharma US Inc | $526.79 | 23 | $0 (2022) |
| ABBVIE INC. | $490.77 | 24 | $0 (2024) |
| PFIZER INC. | $472.82 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $999.87 | 49 | GlaxoSmithKline, LLC. ($278.72) |
| 2023 | $975.65 | 51 | GlaxoSmithKline, LLC. ($215.02) |
| 2022 | $1,077 | 65 | GlaxoSmithKline, LLC. ($295.12) |
| 2021 | $1,626 | 100 | GlaxoSmithKline, LLC. ($236.20) |
| 2020 | $1,369 | 89 | Amarin Pharma Inc. ($225.87) |
| 2019 | $1,293 | 106 | GlaxoSmithKline, LLC. ($263.49) |
| 2018 | $2,146 | 167 | Merck Sharp & Dohme Corporation ($312.80) |
| 2017 | $2,950 | 195 | Boehringer Ingelheim Pharmaceuticals, Inc. ($434.79) |
All Payment Transactions
822 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: VACCINES | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Oncology | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: VACCINES | ||||||
| 06/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,714 | 3,719 | $430,222 | $164,276 |
| 2022 | 37 | 2,510 | 3,452 | $359,377 | $140,448 |
| 2021 | 32 | 2,576 | 5,287 | $419,631 | $156,507 |
| 2020 | 43 | 3,602 | 6,755 | $483,212 | $188,067 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 842 | $222,602 | $71,290 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 216 | 216 | $57,607 | $28,103 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 110 | $20,565 | $6,935 | 33.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 30 | $17,099 | $6,703 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 77 | $11,131 | $5,539 | 49.8% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 21 | 21 | $10,340 | $5,067 | 49.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 205 | 205 | $7,749 | $3,778 | 48.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 195 | 195 | $7,371 | $3,611 | 49.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 158 | 199 | $5,329 | $2,598 | 48.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $7,407 | $2,543 | 34.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 78 | $5,023 | $2,460 | 49.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $5,876 | $2,307 | 39.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 17 | 17 | $4,538 | $2,224 | 49.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 183 | 263 | $4,508 | $2,209 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 161 | 209 | $4,414 | $2,153 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,633 | $2,105 | 27.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 168 | 227 | $3,528 | $1,720 | 48.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 48 | $3,091 | $1,515 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 88 | $2,957 | $1,448 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 113 | 151 | $2,932 | $1,428 | 48.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 47 | 67 | $2,270 | $1,112 | 49.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 31 | 34 | $2,013 | $957.33 | 47.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 24 | 35 | $1,807 | $885.15 | 49.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 18 | 20 | $1,651 | $809.00 | 49.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 42 | 42 | $1,622 | $794.64 | 49.0% |
About Dr. Peter Lautenbach, DO
Dr. Peter Lautenbach, DO is a Family Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447214374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lautenbach, DO has received a total of $12,437 in payments from pharmaceutical and medical device companies, with $999.87 received in 2024. These payments were reported across 822 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($12,287).
As a Medicare-enrolled provider, Lautenbach has provided services to 11,402 Medicare beneficiaries, totaling 19,213 services with total Medicare billing of $649,298. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fort Myers, FL
- Active Since 04/17/2006
- Last Updated 02/06/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447214374
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,141
- XARELTO (Drug) $1,035
- Vascepa (Drug) $878.52
- JANUVIA (Drug) $655.50
- ANORO (Drug) $519.06
- FARXIGA (Drug) $486.33
- Livalo (Drug) $330.75
- Ozempic (Drug) $297.52
- MYRBETRIQ (Drug) $289.25
- STIOLTO RESPIMAT (Drug) $280.46
- VRAYLAR (Drug) $269.46
- Tresiba (Drug) $260.22
- ENTRESTO (Drug) $255.92
- JARDIANCE (Drug) $212.67
- BREZTRI (Drug) $174.18
- SYMBICORT (Drug) $167.01
- CHANTIX (Drug) $163.80
- Trintellix (Drug) $163.46
- EVENITY (Biological) $162.49
- Cologuard Collection Kit (Device) $160.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fort Myers
Dr. Shannon Greer, D.o, D.O
Family Medicine — Payments: $88,641
Derek Dewitt, D.o, D.O
Family Medicine — Payments: $17,375
Dr. Frederick Burford, D.o, D.O
Family Medicine — Payments: $11,863
Ms. Carmen Fernandez, D.o, D.O
Family Medicine — Payments: $9,756
Dr. Rebekah Bernard, Md, MD
Family Medicine — Payments: $8,435
Dr. Robert Pritt, D.o, D.O
Family Medicine — Payments: $7,829